Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RegenCen vs Vea Health

RegenCen
Graded #335

Higher grade

vs+4.799999999999997
Vea Health
Graded #451

Lower grade

The verdict

RegenCen takes it — 59.8/100 to 55/100.

RegenCen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RegenCen is a women's and menopause-focused practice offering its Medically Guided Weight Loss program with GLP-1 medications including semaglutide and tirzepatide, paired with peptides, metabolic care, and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationVea Health +11
40
51
Clinical oversightRegenCen +14
80
66
Labs & monitoringRegenCen +33
85
52
FulfillmentVea Health +6
62
68
Contract termsEven
55
55
RegenCen · left barVea Health · right bar

The numbers

MetricRegenCenVea Health
WeighScore59.8/10055/100
GradeCC
Scorecard rank#335#451
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage2 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
RegenCen

Graded #335 · C

Strengths

  • Virtual consultations by video or phone for MI and FL patients
  • MD-led oversight (Dr. Gustav Lo) plus PA co-founder
  • Menopause Society Certified Practitioners on staff
  • GLP-1 paired with coaching and metabolic care
  • Bundles weight loss with bioidentical hormone therapy

Where it loses points

  • Telehealth limited to Michigan and Florida
  • No published GLP-1 medication pricing
  • No named pharmacy or medication sourcing details
  • Menopause/women's focus rather than weight-loss-only
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard